Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$25.61 - $35.1 $122,928 - $168,480
-4,800 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$33.54 - $40.55 $14,690 - $17,760
-438 Reduced 8.36%
4,800 $161,000
Q2 2021

Aug 10, 2021

BUY
$34.54 - $47.25 $180,920 - $247,495
5,238 New
5,238 $209,000
Q4 2020

Feb 08, 2021

SELL
$45.3 - $60.27 $2,219 - $2,953
-49 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$46.85 - $61.05 $255,473 - $332,905
-5,453 Reduced 99.11%
49 $3,000
Q1 2020

May 08, 2020

BUY
$41.6 - $63.4 $228,883 - $348,826
5,502 New
5,502 $260,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Agf Investments Inc. Portfolio

Follow Agf Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments Inc. with notifications on news.